Publications by authors named "Martin Duddy"

Claim this Profile
E
Effect of repurposed simvastatin on disability progression in secondary progressive multiple sclerosis (MS-STAT2): a phase 3, randomised, double-blind, placebo-controlled trial.
Jeremy Chataway, Thomas Williams, James Blackstone, Nevin John, Marie Braisher, Martin Duddy

Lancet· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient selection and outcome of deep brain stimulation for multiple sclerosis-associated tremor.
Menaka Pasangy Paranathala, Russell Mills, Priya Rai, Nicola Pavese, Mohammed Akbar Hussain, Martin Duddy

Br J Neurosurg· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brain reserve and physical disability in secondary progressive multiple sclerosis.
Nevin John, Yingtong Li, Floriana De Angelis, Jonathan Stutters, Ferran Prados Carrasco, Martin Duddy

BMJ Neurol Open· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the effectiveness of simvastatin in slowing the progression of disability in secondary progressive multiple sclerosis (MS-STAT2): protocol for a multicentre, randomised controlled, double-blind, phase 3 clinical trial in the UK.
James Blackstone, Thomas Williams, Jennifer M Nicholas, Ekaterina Bordea, Floriana De Angelis, Martin Duddy

BMJ Open· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neurostructural and Neurophysiological Correlates of Multiple Sclerosis Physical Fatigue: Systematic Review and Meta-Analysis of Cross-Sectional Studies.
Paula M Ellison, Stuart Goodall, Niamh Kennedy, Helen Dawes, Allan Clark, Martin Duddy

Neuropsychol Rev· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Delivering an advice and guidance service in neurology.
Kirstie N Anderson, Naomi Warren, Martin Duddy, Paul McKean, James A L Miller

Pract Neurol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of smoking cessation on multiple sclerosis disease progression.
Jeff Rodgers, Tim Friede, Frederick W Vonberg, Cris S Constantinescu, Alasdair Coles, Martin Duddy

Brain· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early and unrestricted access to high-efficacy disease-modifying therapies: a consensus to optimize benefits for people living with multiple sclerosis.
Massimo Filippi, Romano Danesi, Tobias Derfuss, Martin Duddy, Paolo Gallo

J Neurol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transition to secondary progressive multiple sclerosis: The consequences for patients and healthcare systems, a healthcare professional survey.
Sophie Clare Laura Caseby, Fern Amy Woodhouse, Stephen Maxwell Montgomery, Michel Anton Kroes, Martin Edward Duddy

Health Sci Rep· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results from SPECTRUM: A survey of healthcare professionals to understand current diagnosis and management practices for secondary progressive multiple sclerosis in the United Kingdom.
Martin Duddy, Carmel Wilkinson, Steve Medhurst, Katherine Rhys

Mult Scler Relat Disord· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19 is associated with new symptoms of multiple sclerosis that are prevented by disease modifying therapies.
Afagh Garjani, Rodden M Middleton, Rachael Hunter, Katherine A Tuite-Dalton, Alasdair Coles, Martin Duddy

Mult Scler Relat Disord· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Living with secondary progressive multiple sclerosis in Europe: perspectives of multiple stakeholders.
Øivind Torkildsen, Ralf A Linker, Jose Mm Sesmero, Simone Fantaccini, Rainel Sanchez-de la Rosa, Martin Duddy

Neurodegener Dis Manag· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Self-diagnosed COVID-19 in people with multiple sclerosis: a community-based cohort of the UK MS Register.
Nikos Evangelou, Afagh Garjani, Roshan dasNair, Rachael Hunter, Katherine A Tuite-Dalton, Martin Duddy

J Neurol Neurosurg Psychiatry· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Translumbar Embolization of Type II Endoleaks: 12 Years of Experience at a Regional Vascular Centre.
Wiliam Rhodri Thomas, Salil Karkhanis, Jonathan Hopkins, Martin Duddy

Vasc Endovascular Surg· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abdominal Aortic Aneurysm Repair in Renal and Liver Transplant Recipients.
Sobath Premaratne, Jonathan Hopkins, Martin Duddy, Ket Sang Tai, Mark Kay

Vasc Endovascular Surg· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cell-free mitochondrial DNA in progressive multiple sclerosis.
Hannah Lowes, Angela Pyle, Martin Duddy, Gavin Hudson

Mitochondrion· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing the long-term effectiveness of interferon-beta and glatiramer acetate in multiple sclerosis: final 10-year results from the UK multiple sclerosis risk-sharing scheme.
Jacqueline Palace, Martin Duddy, Michael Lawton, Thomas Bregenzer, Feng Zhu

J Neurol Neurosurg Psychiatry· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Outcomes of Ipsilateral Antegrade Angioplasty for Femoropopliteal Disease.
James Cragg, Danielle Lowry, Jonathan Hopkins, David Parker, Mark Kay, Martin Duddy

Vasc Endovascular Surg· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A severe, relapsing case of myelin oligodendrocyte glycoprotein IgG-associated CNS inflammation.
Mariyam Saviour, Shahd Hamid, Perry Moore, Kerry Mutch, Maneesh Bhojak, Martin Duddy

Neurol Clin Pract· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Seizures and Encephalitis in Myelin Oligodendrocyte Glycoprotein IgG Disease vs Aquaporin 4 IgG Disease.
Shahd H M Hamid, Dan Whittam, Mariyam Saviour, Amal Alorainy, Kerry Mutch, Martin Duddy

JAMA Neurol· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eosinophilic angiitis presenting with a true, fusiform, temporal artery aneurysm.
Megan MacDiarmid, Dmitri Nepogodiev, Alok Tiwari, Martin Duddy, Martyn Carey

Clin Case Rep· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An observational study of alemtuzumab following fingolimod for multiple sclerosis.
Mark Willis, Owen Pearson, Zsolt Illes, Tobias Sejbaek, Christian Nielsen, Martin Duddy

Neurol Neuroimmunol Neuroinflamm· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The state of multiple sclerosis: current insight into the patient/health care provider relationship, treatment challenges, and satisfaction.
Mar Tintoré, Maggie Alexander, Kathleen Costello, Martin Duddy, David E Jones

Patient Prefer Adherence· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The UK Risk-Sharing Scheme for interferon-beta and glatiramer acetate in multiple sclerosis. Outcome of the year-6 analysis.
Martin Duddy, Jacqueline Palace

Pract Neurol· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors Affecting the Results of Superficial Femoral Artery Stenting.
Mark Kay, Radu Rogoveanu, James Hodson, Simon Tallowin, Jonathan Hopkins, Martin Duddy

Vasc Endovascular Surg· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis